Usefulness of Prebiopsy Multifunctional and Morphologic MRI Combined With Free-to-Total Prostate-Specific Antigen Ratio in the Detection of Prostate Cancer

被引:71
|
作者
Vilanova, Joan C. [1 ,2 ,3 ]
Barcelo-Vidal, Carles [4 ]
Comet, Josep [5 ]
Boada, Maria [1 ]
Barcelo, Joaquim [1 ,2 ,3 ]
Ferrer, Joana [3 ]
Albanell, Joan [3 ]
机构
[1] Clin Girona, Dept MRI, Girona 17002, Spain
[2] Univ Girona, Fac Med, Dept Med Sci, Girona, Spain
[3] Hosp St Caterina, Dept Radiol, Girona, Spain
[4] Univ Girona, Dept Comp Sci & Appl Math, Girona, Spain
[5] Hosp Dr J Trueta, Dept Urol, Girona, Spain
关键词
contrast-enhanced MRI; diffusion; MRI; prostate; spectroscopy; APPARENT DIFFUSION-COEFFICIENT; CONTRAST-ENHANCED MRI; PERIPHERAL ZONE; WEIGHTED MRI; LOCALIZATION; VALUES; SPECTROSCOPY; TRANSITION; BIOPSY; TISSUE;
D O I
10.2214/AJR.10.5700
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The purpose of the study was to assess the predictive value for prostate cancer of MRI using morphologic (T2-weighted imaging [T2WI]) and functional (MR spectroscopy [MRS], diffusion-weighted imaging [DWI], and dynamic contrast-enhanced [DCE] MRI) sequences and the free-to-total prostate-specific antigen (PSA) ratio, alone and combined. MATERIALS AND METHODS. This retrospective study included 70 patients (PSA level, > 4 ng/mL; free-to-total PSA ratio, < 20%) who underwent endorectal 1.5-T MRI before biopsy. We graded the likelihood of cancer on a 5-point scale. Imaging data were compared with histologic results on biopsy or prostatectomy. Accuracies were estimated from the area under receiver operating characteristic using the hemiprostate as the unit of analysis. A p value less than 0.05 denoted statistical significance. RESULTS. The model combining all variables was more accurate than each variable alone (95.2% vs 73.5% for T2WI, 76.0% for MRS, 81.8% for DWI, 75.6% for DCE-MRI, and 78.8% for free-to-total PSA ratio). The complete model had accuracy similar to that of combining two imaging variables with free-to-total PSA ratio, especially free-to-total PSA ratio, T2WI, and DWI (94.0%); and free-to-total PSA ratio, DWI, and MRS (93.8%); with negative predictive values of 91.0% and 89.5%, respectively. The best models combining two imaging variables (MRS and DWI, 85.8%; T2WI and DWI, 84.8%) had accuracy that was similar to that of the combination of all imaging variables (87.3%) and higher than that of the best individual imaging variable (DWI, 81.8%), but lower than that of the complete model. CONCLUSION. The combination of at least one functional technique with free-to-total PSA ratio is more accurate than combining only imaging variables in cancer detection. The use of more than two imaging variables does not increase the detection rate. Functional MRI has the potential to help avoid a large number of negative biopsies.
引用
收藏
页码:W715 / W722
页数:8
相关论文
共 50 条
  • [1] On the clinical usefulness of the free-to-total prostate-specific antigen ratio
    Ciatto, S
    Rubeca, T
    Franceschini, R
    Trevisiol, C
    Confortini, M
    Pontenani, G
    Lombardi, C
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2006, 21 (01): : 1 - 5
  • [2] Value of free-to-total prostate-specific antigen ratio for detection and staging of prostate cancer
    Furuya Y.
    Akakura K.
    Ito H.
    International Journal of Clinical Oncology, 2000, 5 (1) : 8 - 11
  • [3] Limited usefulness of the free-to-total prostate-specific antigen ratio for the diagnosis and staging of prostate cancer in Japanese men
    Sakai I.
    Harada K.-I.
    Hara I.
    Eto H.
    Miyake H.
    International Journal of Clinical Oncology, 2004, 9 (1) : 64 - 67
  • [4] Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels
    Richard M. Hoffman
    David L. Clanon
    Benjamin Littenberg
    Joseph J. Frank
    John C. Peirce
    Journal of General Internal Medicine, 2000, 15 : 739 - 748
  • [5] Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels
    Hoffman, RM
    Clanon, DL
    Littenberg, B
    Frank, JJ
    Peirce, JC
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 (10) : 739 - 748
  • [6] Prostate-specific antigen adjusted for the transition zone volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer
    Moon, DG
    Cheon, J
    Kim, JJ
    Yoon, DK
    Koh, SK
    INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (09) : 455 - 462
  • [7] Effect of prostatic biopsy on free-to-total prostate-specific antigen ratio in patients with prostate cancer
    Furuya, Y
    Akakura, K
    Ichikawa, T
    Masai, M
    Igarashi, T
    Ito, H
    INTERNATIONAL JOURNAL OF UROLOGY, 2000, 7 (02) : 49 - 53
  • [8] Change in the ratio of free-to-total prostate-specific antigen during progression of advanced prostate cancer
    Tanaka, M
    Murakami, S
    Suzuki, N
    Shimazaki, J
    INTERNATIONAL JOURNAL OF UROLOGY, 2000, 7 (03) : 83 - 87
  • [9] Activity does not affect free and total prostate-specific antigen levels but lowers the free-to-total prostate-specific antigen ratio
    Ulman, C
    Buyukyazi, G
    Taneli, F
    Uyanik, BS
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2004, 32 (06) : 583 - 589
  • [10] EVALUATION OF FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN RATIO IN THE DIAGNOSIS OF PROSTATE CANCER
    邵远
    张祖豹
    Chinese Journal of Cancer Research, 2000, (02) : 114 - 114